| HOME >> MEDICINE >> TECHNOLOGY |
$ 15,384$ 16,814$ (1,430)-9%Consumable sales
22,70233,399(10,697)-32%Royalty revenue
15,95714,6681,2899%Assay revenue
34,80718,84515,96285%All other revenue
8,1507,18796313%$ 97,000$ 90,913$ 6,0877%"We are pleased with our revenue progress, notwithstanding the significant decline in current quarter consumable revenue which was primarily the result of volatility in a single customer's purchases," said Harriss T. Currie, vice president and chief financial officer. "We anticipate improved revenue growth in the second half of 2012, as a result of both traction within our LMA and LMD product portfolios and easing consumable revenue comparisons." LUMINEX CORPORATIONREPORTABLE SEGMENT HIGHLIGHTS(in thousands, except percentages)Three Months EndedJune 30,Variance20122011($)(%)(unaudited)RevenueTechnology and strategic partnerships
$ 29,565$ 36,211$ (6,646)-18%Assays and related products
18,70811,4277,28164%Total Revenue
48,27347,6386351%Operating income (loss)Technology and strategic partnerships
4,34211,572(7,230)-62%Assays and related products
2,144(2,775)4,919177%Total Operating income
6,4868,797(2,311)-26%Six Months EndedJune 30,Variance20122011($)(%)(unaudited)RevenueTechnology and strategic partnerships
$ 59,774$ 68,146$ (8,372)-12%Assays and related products
37,22622,76714,45964%Total Revenue
97,00090,9136,0877%Operating income (loss)Technology and strategic partnerships
8,54120,228(11,687)-58%Assays and related products
3,553(3,137)6,690213%Total Operating income
12,09417,091(4,997)-29%
FINANCIAL OUTLOOK AND GUIDANCE The Company reaffirms its 2012 annual revenue guidance of between $205 and $215 million.
CONFERENCE CALL Management will host a conference call to dis
'/>"/>
| SOURCE Luminex Corporation Copyright©2012 PR Newswire. All rights reserved |